Abstract: The present invention addresses deficiencies of the art with respect to collaborative computer networks consisting of mixed data, control functions, analysis functions, and sensors in complex systems of systems. The method involves a database framework for representing complex heterogeneous characteristics of processes, systems, and systems of systems that feature many to many interrelationships. The homoiconic graph framework takes the form of an executable graph database, which is often faster for associative data sets, and maps more directly to object-oriented computer applications for large-scale operations. The invention provides a method to execute the graph database, in that it comprises nodes that are both data fragments and executable components. It is characterized as a homoiconic or executable graph framework to distinguish this unique feature from the concept of a graph database, which generally is a repository of connected data only.

Abstract: The present invention addresses deficiencies of the art with respect to collaborative computer networks consisting of mixed data, control functions, analysis functions, and sensors in complex systems of systems. The method involves a database framework for representing complex heterogeneous characteristics of processes, systems, and systems of systems that feature many to many interrelationships. The homoiconic graph framework takes the form of an executable graph database, which is often faster for associative data sets, and maps more directly to object-oriented computer applications for large-scale operations. The invention provides a method to execute the graph database, in that it comprises nodes that are both data fragments and executable components. It is characterized as a homoiconic or executable graph framework to distinguish this unique feature from the concept of a graph database, which generally is a repository of connected data only.

Abstract: A means and method for treating pulmonary fibrosis and vaginitis in animals is described. The compositions include surfactant lipids in a pharmaceutically acceptable carrier. Surfactant lipids have been found to suppress the synergistic effect of bleomycin and SP-A in enhancing proinflammatory cytokine production. Surfactant lipids are also effective in the prevention and treatment of pulmonary fibrosis resulting from exposure to inflammatory agents affecting cytokine production. Furthermore, surfactant lipids are effective in treating attenuating the effect of proinflammatory cytokine production in vaginitis.

Abstract: A means and method for treating pulmonary fibrosis in animals is described. The compositions include surfactant lipids in a pharmaceutically acceptable carrier. Surfactant lipids have been found to suppress the synergistic effect of bleomycin and SP-A in enhancing proinflammatory cytokine production. Surfactant lipids are also effective in the prevention and treatment of pulmonary fibrosis resulting from exposure to inflammatory agents affecting cytokine production.

Abstract: A means and method for treating pulmonary fibrosis and vaginitis in animals is described. The compositions include surfactant lipids in a pharmaceutically acceptable carrier. Surfactant lipids have been found to suppress the synergistic effect of bleomycin and SP-A in enhancing proinflammatory cytokine production. Surfactant lipids are also effective in the prevention and treatment of pulmonary fibrosis resulting from exposure to inflammatory agents affecting cytokine production. Furthermore, surfactant lipids are effective in treating attenuating the effect of proinflammatory cytokine production in vaginitis.

Abstract: A means and method for treating pulmonary fibrosis in animals is described. The compositions include surfactant lipids in a pharmaceutically acceptable carrier. Surfactant lipids have been found to suppress the synergistic effect of bleomycin and SP-A in enhancing proinflammatory cytokine production. Surfactant lipids are also effective in the prevention and treatment of pulmonary fibrosis resulting from exposure to inflammatory agents affecting cytokine production.

Abstract: This invention relates to novel proteins useful for enhancing pulmonary surfactant activity, methods and materials for obtaining said proteins and compositions containing one or more of the proteins.

Abstract: An apparatus for slicing food products, including potatoes and the like, includes a plurality of perpendicularly intersecting knife blades of chevron configuration which are arranged in a substantially pyramidal formation. The apex of the pyramidal formation and apexes of the individual blades point downstream, away from the direction of flow of a fluid stream which carries the potatoes toward the knife assembly for slicing. The blades are mounted by a unitary fixture having a cylindrical bore and mounting the blades such that the farthest upstream blades are spaced farthest away from the axial center of the blade assembly, with successive downstream blades being spaced incrementally closer to such axial center. The blades are further mounted such that no parallel blades axially overlap one another.

Abstract: This invention relates to novel proteins useful for enhancing pulmonary surfactant activity, methods for obtaining said proteins and compositions containing one or more of the proteins. The proteins of this invention include the following:1. A protein characterized by a molecular weight of about 35 kd and by being encoded for by the DNA sequence depicted in Table 1.2. A protein characterized by a molecular weight of about 35 kd and by being encoded for by the DNA sequence depicted in Table 2.3. A protein encoded for by a portion of the DNA sequence depicted in Table 6 and characterized by a molecular weight of about 5.5-9 kd; and4. A protein characterized by a molecular weight of about 5.5-9 kd and an amino acid composition as set forth in Table 4.